跳至主要内容
临床试验/NCT06277895
NCT06277895招募中不适用

Application of Emergency Rapid Detection of Expiratory Volatile Organic Compounds (VOCs) in Patients With Acute Cardiogenic Chest Pain

Qilu Hospital of Shandong University1 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2024年1月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,400
试验地点
1
主要终点
Baseline VOCs (aldehydes) levels in healthy population

研究概览

简要总结

The goal of this observation study is to compare VOCs in cardiogenic chest pain population/health conditions, to answer:Establishment and promotion of the application system of emergency rapid detection of expiratory Volatile Organic Compounds (VOCs) in patients with acute cardiogenic chest pain

  1. VOCs levels were measured at baseline in healthy people, and markers of VOCs that could be used to identify acute cardiogenic chest pain were sought.
  2. The relationship between abnormal VOCs (mainly aldehydes) and prognosis of patients and the correlation with Super-score for early warning of acute heart failure.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Observation group inclusion criteria:
  • Over 18 years old, male or female;
  • Patients with acute cardiogenic chest pain (see diagnostic criteria);
  • Patient's informed consent.
  • Inclusion criteria of healthy control group:
  • Over 18 years old, male or female;
  • Centerless cerebrovascular disease, lung disease, no abnormal liver and kidney function, no acute infection recently;
  • Informed consent.

排除标准

  • The patient had difficulty in collecting breath;
  • Patients with terminal illness or receiving palliative care;
  • Have participated in other clinical studies or consider it inappropriate to participate in this study.

研究组 & 干预措施

normal group

Other

Healthy population

干预措施: VOCs (Diagnostic Test)

cardiogenic chest pain group

Experimental

cardiogenic chest pain group/acute coronary syndrome

干预措施: VOCs (Diagnostic Test)

结局指标

主要结局

Baseline VOCs (aldehydes) levels in healthy population

时间窗: Baseline

Baseline VOCs (aldehydes) levels in healthy population

次要结局

  • MACE in patients with cardiogenic chest pain(From enrollment to the end of treatment at 30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

VOCs in Patients With Acute Cardiogenic Chest Pain | 临床试验